Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of 368.68 million. The enterprise value is 454.57 million.
| Market Cap | 368.68M |
| Enterprise Value | 454.57M |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.54 billion shares outstanding. The number of shares has increased by 16.16% in one year.
| Current Share Class | 1.54B |
| Shares Outstanding | 1.54B |
| Shares Change (YoY) | +16.16% |
| Shares Change (QoQ) | +3.64% |
| Owned by Insiders (%) | 7.03% |
| Owned by Institutions (%) | 0.05% |
| Float | 1.43B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 393.47 |
| PB Ratio | -3.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.99 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.94 |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.51 |
| Interest Coverage | -7.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -135.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 113.29% |
| Revenue Per Employee | 37,480 |
| Profits Per Employee | -3.65M |
| Employee Count | 25 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.64% in the last 52 weeks. The beta is -0.84, so NWBO's price volatility has been lower than the market average.
| Beta (5Y) | -0.84 |
| 52-Week Price Change | -18.64% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 48.95 |
| Average Volume (20 Days) | 3,788,617 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NWBO had revenue of 937,000 and -91.15 million in losses. Loss per share was -0.07.
| Revenue | 937,000 |
| Gross Profit | -33.95M |
| Operating Income | -64.91M |
| Pretax Income | -89.77M |
| Net Income | -91.15M |
| EBITDA | -63.14M |
| EBIT | -64.91M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 4.56 million in cash and 77.05 million in debt, giving a net cash position of -72.49 million or -0.05 per share.
| Cash & Cash Equivalents | 4.56M |
| Total Debt | 77.05M |
| Net Cash | -72.49M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | -95.25M |
| Book Value Per Share | -0.07 |
| Working Capital | -80.71M |
Cash Flow
In the last 12 months, operating cash flow was -50.18 million and capital expenditures -677,000, giving a free cash flow of -50.86 million.
| Operating Cash Flow | -50.18M |
| Capital Expenditures | -677,000 |
| Free Cash Flow | -50.86M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -6,927.32% |
| Pretax Margin | -9,580.90% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.16% |
| Shareholder Yield | -16.16% |
| Earnings Yield | -24.72% |
| FCF Yield | -13.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |